Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
n mutations). Economics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
n mutations). Economics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
n mutations). Economics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes
Sponsored
2 mentions1 same-page
Page ?Same page
m pests and invasive species. Lead by Kevin Esvelt. This will probably be in the news on July 17. Business model similar to the relationship between Amyris and the Gates Foundation for manufacturing anti-malaria drugs. 6) Making human genetic disease models in organoids and aging reversal using CRISPR
n mutations). Economics could be like the American Bison which recently grew from a hundred to 500,000 as a source of low cholesterol meat. Lead by Margo Monroe and Justin Quinn. Possibly mergeable with EgenesisBio. 10) The rest would be set aside as a second tranche for whichever of the above efforts makes
Sponsored
Mutual Connections (18)
Entities connected to both Amyris and Margo Monroe
Jeffrey Epstein
PERSON7 w/ Amyris·4 w/ Margo
Marc Rich
PERSON7 w/ Amyris·4 w/ Margo
JQ
Justin Quinn
PERSON4 w/ Amyris·4 w/ Margo
Robert Gates
PERSON4 w/ Amyris·4 w/ Margo
Justin Trudeau
PERSON4 w/ Amyris·4 w/ Margo
JC
James Clement
PERSON4 w/ Amyris·4 w/ Margo
KE
Kevin Esvelt
PERSON4 w/ Amyris·4 w/ Margo
Space Genetics
ORGANIZATION4 w/ Amyris·4 w/ Margo
PM
Prashant Mali
PERSON4 w/ Amyris·4 w/ Margo
DM
Dan Mandell
PERSON4 w/ Amyris·4 w/ Margo
RT
Rich Terry
PERSON4 w/ Amyris·4 w/ Margo
BD
Bobby Dhadwar
PERSON4 w/ Amyris·4 w/ Margo
TW
Ting Wu
PERSON4 w/ Amyris·4 w/ Margo
the American Bison
ORGANIZATION3 w/ Amyris·3 w/ Margo
ES
Eswar
PERSON3 w/ Amyris·3 w/ Margo
LY
Luhan Yang
PERSON3 w/ Amyris·3 w/ Margo
Eric Trump
PERSON3 w/ Amyris·2 w/ Margo
HE
Helicos
PERSON2 w/ Amyris·2 w/ Margo